The Cancer & Cognition Platform actively participated in the 2016 ICCTF Conference that took place in Amsterdam on March 14-16.
Communications:
- Prospective evaluation of the impact of antiangiogenic treatment on cognitive functions in metastatic renal cancer, March 14, Florence Joly, MD PhD
- Co-Organisation of the SYMPOSIUM 2 “Chemotherapy-induced cognitive impairment. An animal model approach”, March 16, Hélène Castel.
- Pre-clinical animal models and targeted therapies on cognition. Direct impact of the PI3K Inhibitor buparlisib, March 16, Hélène Castel, PhD
